IL33 and neoplasm: IL-33 is expressed at high levels in the tumor microenvironment19, and during cancer progression, IL-33 is upregulated in the tumor stroma and serum, where it facilitates immune suppression via T-regulatory cells (T-regs) and myeloid-derived suppressor cells19,20, although its effects depend on the level of expression21.